{
  "resourceType": "ValueSet",
  "id": "BiRadsAssessmentCategoriesVS",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h2>BiRads(r) Assessment Category ValueSet</h2><div><p>BiRads(r) Assessment Category value set.</p>\n</div><ul><li>Include these codes as defined in <a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html\"><code>http://hl7.org/fhir/us/breast-radiology/CodeSystem/BiRadsAssessmentCategoriesCS</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category0\">Category0</a></td><td>Category 0 (Incomplete)</td><td>Need additional Imaging Evaluation and/or prior Mammograms <br/>for comparison. <br/>Recall for additional imaging and/or comparison with <br/>prior examination(s) <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category2\">Category2</a></td><td>Category 2 (Benign)</td><td>This is a normal assessment. <br/>Benign refers to a condition, tumor, or growth that <br/>is not cancerous. <br/>This means that it does not spread to other parts <br/>of the body. <br/>It does not invade nearby tissue. <br/>Essentially 0% likelihood of malignancy. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category3\">Category3</a></td><td>Category 3 (Probably Benign)</td><td>A finding assessed using this category should have <br/>a &lt;= 2% likelihood of malignancy, <br/>but greater than the essentially 0% likelihood of <br/>malignancy of a characteristically <br/>benign finding. <br/>A probably benign finding is not expected to change <br/>over the suggested period of <br/>imaging surveillance, but the interpreting physician <br/>prefers to establish stability <br/>of the finding before recommending management limited <br/>to routine mammography screening. <br/>Six month follow-up and/or <br/>surveillance mammography is recommended. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category4\">Category4</a></td><td>Category 4 (Suspicious)</td><td>This category is reserved for findings that do not <br/>have the classic appearance of <br/>malignancy but are sufficiently suspicious to justify <br/>a recommendation for biopsy. <br/>There is a 2% likelihood of malignancy (cancer). <br/>Almost all recommendations for breast interventional <br/>procedures will come from assessments <br/>made using <br/>this category. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category4A\">Category4A</a></td><td>Category 4A (Low suspicion)</td><td>Low suspicion for malignancy. <br/>A malignant finding is not suspected. <br/>A biopsy or other test will likely still be performed <br/>in order to determine. <br/>Tissue diagnosis may be recommended. <br/>Six month follow-up and/or surveillance mammography <br/>is recommended. <br/>Likelihood of malignancy is &gt; 2% to &lt;= 10% likelihood <br/>of malignancy. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category4B\">Category4B</a></td><td>Category 4B (Moderate suspicion)</td><td>Category 4B: Moderate suspicion for malignancy. <br/>It warrants radiologic and pathologic correlation <br/>after tissue diagnosis. <br/>Likelihood of malignancy is &gt; 10% to &lt;= 50% likelihood <br/>of <br/>malignancy. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category4C\">Category4C</a></td><td>Category 4C (High suspicion)</td><td>Category 4C: High suspicion for <br/>malignancy. <br/>Includes findings that have a high suspicion of malignancy <br/>but that are not highly <br/>suggestive of malignancy (category 5). <br/>Tissue Diagnosis is highly recommended. <br/>Range for likelihood of malignancy is &gt; 50% to &lt; <br/>95% likelihood of malignancy. <br/>It is more likely malignant versus benign. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category5\">Category5</a></td><td>Category 5 (Highly Suggestive of Malignancy)</td><td>Highly Suggestive of Malignancy. <br/>Almost certainly predictive of breast cancer with <br/>a <br/>value of at least 95%. <br/>Tissue Diagnosis is highly recommended or required. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr><tr><td><a href=\"CodeSystem-BiRadsAssessmentCategoriesCS.html#BiRadsAssessmentCategoriesCS-Category6\">Category6</a></td><td>Category 6 (Known Biopsy-Proven Malignancy)</td><td>Known Biopsy-Proven Malignancy. <br/>Surgical excision when clinically <br/>appropriate. <br/>This category is only used for findings on a mammogram <br/>that have already been shown to be cancer by a previous <br/>biopsy. <br/>Mammograms may be used in this way to see how well <br/>the cancer is responding to treatment. <br/>[Breast Imaging Reporting and Data System—Mammography, Fifth Edition] <br/><br/>Valid for the following modalities: MG US MRI NM.</td></tr></table></li></ul></div>"
  },
  "url": "http://hl7.org/fhir/us/breast-radiology/ValueSet/BiRadsAssessmentCategoriesVS",
  "version": "0.2.0",
  "name": "BiRadsAssessmentCategoriesVS",
  "title": "BiRads(r) Assessment Category ValueSet",
  "status": "draft",
  "date": "2019-11-01T00:00:00+00:00",
  "publisher": "Hl7 - Clinical Interoperability Council",
  "contact": [
    {
      "telecom": [
        {
          "system": "url",
          "value": "http://hl7.org/Special/committees/cic"
        }
      ]
    }
  ],
  "description": "BiRads(r) Assessment Category value set.",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code": "001"
        }
      ]
    }
  ],
  "compose": {
    "include": [
      {
        "system": "http://hl7.org/fhir/us/breast-radiology/CodeSystem/BiRadsAssessmentCategoriesCS",
        "concept": [
          {
            "code": "Category0",
            "display": "Category 0 (Incomplete)"
          },
          {
            "code": "Category2",
            "display": "Category 2 (Benign)"
          },
          {
            "code": "Category3",
            "display": "Category 3 (Probably Benign)"
          },
          {
            "code": "Category4",
            "display": "Category 4 (Suspicious)"
          },
          {
            "code": "Category4A",
            "display": "Category 4A (Low suspicion)"
          },
          {
            "code": "Category4B",
            "display": "Category 4B (Moderate suspicion)"
          },
          {
            "code": "Category4C",
            "display": "Category 4C (High suspicion)"
          },
          {
            "code": "Category5",
            "display": "Category 5 (Highly Suggestive of Malignancy)"
          },
          {
            "code": "Category6",
            "display": "Category 6 (Known Biopsy-Proven Malignancy)"
          }
        ]
      }
    ]
  }
}